Skip to content
Curcumin C3 Reduct®
  • Curcumin C3 Reduct®
    • Introduction
    • Chemistry
    • Pharmacokinetics
    • Advantages
  • Research
    • Pre-clinical
    • Clinical
    • Safety Studies
    • References
  • IP Rights
    • Patents
  • About Sabinsa
    • Newsroom
      • Press Release
      • Media Coverage
      • White Papers
      • Newsletters
      • Articles
      • Milestones
      • Ads
  • Contact Us

Sabinsa’s VP scientific affairs Dr. Pande featured in probiotics podcast providing details on LactoSpore®

Sabinsa’s Vice President of Scientific Affairs Anurag Pande Ph.D. was interviewed in depth on probiotics for a Natural Products Insider podcast. Dr. Pande explained Sabinsa’s shelf-stable probiotic LactoSpore® (Bacillus coagulans MTCC 5856) in detail, including what “spore forming” means, how it is different from other probiotics, what effects Bacillus coagulans has on human health, and what research backs safety and efficacy.

This podcast previews Dr. Pande’s upcoming presentation at Probiotics Marketplace, a day-and-a-half event co-sponsored by Sabinsa to provide insights on probiotic science and formulation, as well as issues to consider for an effective go-to-market strategy, on April 18 and 19 in Orlando Florida as part of Ingredient Marketplace, the East Coast sister show to Supply Side West.

The podcast can be heard here: Natural Products Insider

Back

About Sabinsa

Sabinsa is a manufacturer, supplier and marketer of herbal extracts, cosmeceuticals, minerals, dietary supplements and specialty fine chemicals for the nutritional, cosmetic, pharmaceutical and food industries.

Read More..

Headquarters

Sabinsa Corporation

20 Lake Drive 

East Windsor

NJ 08520, USA

 

Tel : +1 732 777 1111

Fax: +1 732 777 1443

info@sabinsa.com

Global Contact List

USA India
Utah, USA Japan
Australia Poland
Brasil Korea
Canada South Africa
China Vietnam
Germany  

Contact us

    © 2025 Sabinsa. All Rights Reserved | Privacy Policy | Sitemap | Terms of Use | Disclaimer

    ×

    Disclaimer

    US-FDA: This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

    Usage disclaimer: The information pertaining to any marketing materials by Sabinsa, is for general purposes only. Users are urged to check the validity of patents if any, on any Sabinsa items for their intended use.

    EFSA: This statement has not been evaluated by the EFSA. This product is not intended to diagnose, treat, cure, or prevent any disease.

    Australia: Please note as an ingredient supplier the information contained in this website is for marketers of finished products formulations and is not intended as consumer advice. Marketers should ensure finished products are lawful and comply with the regulations of the countries in which these items are sold. Every care has been taken to ensure the accuracy of the information provided at the time of publication.